275 related articles for article (PubMed ID: 15937694)
1. TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model.
Cernaianu G; Frank S; Erbstösser K; Leonhardt S; Cross M; McIvor Z; Scholz G; Dansranjavin T; Celik I; Tannapfel A; Wittekind C; Troebs RB; Rothe K; Bennek J; Hauss J; Witzigmann H
Int J Colorectal Dis; 2006 Mar; 21(2):143-54. PubMed ID: 15937694
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
Ma J; Pulfer S; Li S; Chu J; Reed K; Gallo JM
Cancer Res; 2001 Jul; 61(14):5491-8. PubMed ID: 11454697
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T
Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antitumor effect of an angiogenesis inhibitor (TNP-470) and tumor necrosis factor in mice.
Amikura K; Matsuno S; Egawa S
Surg Today; 2006; 36(12):1069-74. PubMed ID: 17123135
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effects of TNP-470 in combination with 5-fluorouracil on growth of human colon cancer].
Fan YF; Huang ZH; Nie J
Ai Zheng; 2002 Dec; 21(12):1319-23. PubMed ID: 12520739
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of inflammatory corneal angiogenesis by TNP-470.
Joussen AM; Beecken WD; Moromizato Y; Schwartz A; Kirchhof B; Poulaki V
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2510-6. PubMed ID: 11581191
[TBL] [Abstract][Full Text] [Related]
8. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with tumor-lysate pulsed dendritic cells and antiangiogenic drug TNP-470 for mouse pancreatic cancer.
Miyazaki J; Tsuzuki Y; Matsuzaki K; Hokari R; Okada Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Int J Cancer; 2005 Nov; 117(3):499-505. PubMed ID: 15906361
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
[TBL] [Abstract][Full Text] [Related]
11. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.
Drevs J; Hofmann I; Hugenschmidt H; Wittig C; Madjar H; Müller M; Wood J; Martiny-Baron G; Unger C; Marmé D
Cancer Res; 2000 Sep; 60(17):4819-24. PubMed ID: 10987292
[TBL] [Abstract][Full Text] [Related]
12. TNP-470 promotes initial vascular sprouting in xenograft tumors.
Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
[TBL] [Abstract][Full Text] [Related]
13. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
Kato T; Sato K; Kakinuma H; Matsuda Y
Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956
[TBL] [Abstract][Full Text] [Related]
14. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
Shusterman S; Grupp SA; Barr R; Carpentieri D; Zhao H; Maris JM
Clin Cancer Res; 2001 Apr; 7(4):977-84. PubMed ID: 11309349
[TBL] [Abstract][Full Text] [Related]
15. Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice.
Dabrowska-Iwanicka A; Olszewska D; Jalili A; Makowski M; Grzela T; Marczak M; Hoser G; Giermasz A; Golab J; Jakóbisiak M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):433-42. PubMed ID: 12200600
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
Jia L; Zhang MH; Yuan SZ; Huang WG
World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
[TBL] [Abstract][Full Text] [Related]
18. Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer.
Nahari D; Satchi-Fainaro R; Chen M; Mitchell I; Task LB; Liu Z; Kihneman J; Carroll AB; Terada LS; Nwariaku FE
Mol Cancer Ther; 2007 Apr; 6(4):1329-37. PubMed ID: 17431111
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis can be reduced without significant reduction of tumor growth.
Svensson A; Bäckman U; Fuchs D; Christofferson R; Azarbayjani F
Anticancer Res; 2007; 27(6B):3883-9. PubMed ID: 18225546
[TBL] [Abstract][Full Text] [Related]
20. Effects of endostatin on expression of vascular endothelial growth factor and its receptors and neovascularization in colonic carcinoma implanted in nude mice.
Jia YH; Dong XS; Wang XS
World J Gastroenterol; 2004 Nov; 10(22):3361-4. PubMed ID: 15484319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]